Novartis Zelnorm Approval: FDA Accepts Overseas History, Active Surveillance

The approval of Novartis' Zelnorm reflects FDA's comfort with an active surveillance program proposed by the company - and the extensive post marketing safety database of the irritable bowel syndrome agent in overseas markets